ArticleBMC cancer2023

RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity.

David Barua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.